SCHEMBL6851652

SCHEMBL6851652

c1ccc(-c2nc3ccccc3cc2CN2CCC(N3CCOCC3)CC2)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TACR3 P29371 5/20 0.50
TACR2 P21452 4/20 0.50
POLB P06746 2/20 0.50
KDM4E B2RXH2 1/20 0.50
ALDH1A1 P00352 1/20 0.50
KMT2A Q03164 1/20 0.50
CYP3A4 P08684 2/20 0.46
CYP2C9 P11712 2/20 0.46
CYP2C19 P33261 2/20 0.46
CYP1A2 P05177 1/20 0.46
TRPV4 Q9HBA0 3/20 0.45
AKT1 P31749 2/20 0.44
KCNH2 Q12809 1/20 0.43
CASP1 P29466 1/20 0.43
HSD17B10 Q99714 1/20 0.43
CYP2D6 P10635 1/20 0.43
HSD11B1 P28845 1/20 0.42
PIK3CA P42336 1/20 0.41
MTOR P42345 1/20 0.41
NAMPT P43490 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6853374 0.84 TACR3 (0.50) TACR3TACR2KDM4EALDH1A1KMT2A
SCHEMBL5945358 0.81 SLC2A1 (0.46) TACR3TACR2AKT1OPRM1
SCHEMBL6853531 0.80 DRD2 (0.50) KDM4EALDH1A1KMT2AAKT1
SCHEMBL6854970 0.77 KMT2A (0.50) KDM4EALDH1A1KMT2AAKT1KCNH2
SCHEMBL6848917 0.77 TACR3 (0.70) TACR3TACR2TRPV4KCNH2OPRM1
SCHEMBL6851740 0.76 AKT1 (0.48) KDM4EALDH1A1AKT1KCNH2HSD17B10
SCHEMBL6853013 0.76 HRH3 (0.48) POLBKDM4EALDH1A1KMT2ACYP2C9
SCHEMBL5442168 0.75 PDE10A (0.43) POLBKDM4EALDH1A1KMT2AAKT1
SCHEMBL6848935 0.73 SLC2A1 (0.44) TACR3TACR2KDM4EALDH1A1KCNH2
SCHEMBL6853077 0.73 HTR2B (0.49) KDM4EALDH1A1KMT2ACYP2C9CASP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6780875-B2 RESPIRATORY SYSTEM DISORDERS; ANTIINFLAMMATORY AGENTS; PSYCHOLOGICAL DISORDERS SMITHKLINE BEECHAM S.P.A. (IT) 2004-08-24 US disclosed